Published in:
01-01-2022 | Myalgie | Concise Research Report
Impact of Metformin on Statin Persistence: a Post Hoc Analysis of a Large Randomized Controlled Trial
Authors:
Byron Cheon, MS, Ambuj Kumar, MD, MPH, Athanasios Tsalatsanis, PhD, Kevin Cowart, PharmD, MPH, Ronald R. Magness, PhD, Srinivas M. Tipparaju, PhD, Nicholas W. Carris, PharmD
Published in:
Journal of General Internal Medicine
|
Issue 1/2022
Login to get access
Excerpt
Optimal cardiovascular disease (CVD) risk reduction is impaired by statin-associated muscle symptoms (SAMS).
1‐3 Severe muscle reactions are well accounted for, yet mild-to-moderate myalgia is common and difficult to track. No valid SAMS therapies exist, and management requires trial-and-error with different statins until one is tolerated.
1 …